Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery.
暂无分享,去创建一个
H. Verbrugh | J. Kluytmans | A. Maat | M. Vandenbergh | B. Hout | J. McDonnel | R. Seerden | M. VandenBergh
[1] H. Verbrugh,et al. Reduction of Surgical-Site Infections in Cardiothoracic Surgery by Elimination of Nasal Carriage of Staphylococcus aureus , 1996, Infection Control & Hospital Epidemiology.
[2] H. Verbrugh,et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. , 1995, The Journal of infectious diseases.
[3] J. Kluytmans,et al. Surveillance of postoperative infections in thoracic surgery. , 1994, The Journal of hospital infection.
[4] B. Doebbeling,et al. Elimination of Staphylococcus aureus Nasal Carriage in Health Care Workers: Analysis of Six Clinical Trials with Calcium Mupirocin Ointment , 1993 .
[5] M. Schumacher,et al. Added Hospital Stay Due to Wound Infections Following Cardiac Surgery , 1992, The Thoracic and cardiovascular surgeon.
[6] R. Ludke,et al. Methods for estimating days of hospitalization due to nosocomial infections. , 1992, Medical care.
[7] L. Nicolle,et al. Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patients. , 1991, The Journal of hospital infection.
[8] B. Doebbeling,et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. , 1991, Annals of internal medicine.
[9] B. Doebbeling,et al. Cardiovascular surgery prophylaxis. A randomized, controlled comparison of cefazolin and cefuroxime. , 1990, The Journal of thoracic and cardiovascular surgery.
[10] R W Stewart,et al. J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. , 1990, The Annals of thoracic surgery.
[11] J. Boyce,et al. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. , 1990, Infection control and hospital epidemiology.
[12] F. Daschner. Cost-effectiveness in hospital infection control--lessons for the 1990s. , 1989, The Journal of hospital infection.
[13] B. Yangco,et al. CDC definitions for nosocomial infections. , 1989, American journal of infection control.
[14] D. Wakefield,et al. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. , 1988, American journal of infection control.
[15] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.
[16] C. Bartzokas,et al. Measuring the saving attributable to an antibiotic prescribing policy. , 1988, The Journal of hospital infection.
[17] D. Kernodle,et al. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients. , 1987, Annals of surgery.
[18] D. Wakefield,et al. Use of the Appropriateness Evaluation Protocol for Estimating the Incremental Costs Associated With Nosocomial Infections , 1987, Medical care.
[19] R. M. Nelson,et al. The economic implications of infection in cardiac surgery. , 1986, The Annals of thoracic surgery.
[20] S. Rishpon,et al. Reliability of a method of determining the necessity for hospitalization days in Israel. , 1986, Medical care.
[21] P. Gertman,et al. A comparative analysis of appropriateness of hospital use. , 1984, Health affairs.
[22] J. Mcgowan,et al. Methodologic issues in hospital epidemiology. III. Investigating the modifying effects of time and severity of underlying illness on estimates of cost of nosocomial infection. , 1984, Reviews of infectious diseases.
[23] E. Rubinstein,et al. Estimating the effects of nosocomial infections on the length of hospitalization. , 1982, The Journal of infectious diseases.
[24] M. Modan,et al. The effects of nosocomial infections on the length and costs of hospital stay. , 1982, The Journal of antimicrobial chemotherapy.
[25] S. Finkler. The distinction between cost and charges. , 1982, Annals of internal medicine.
[26] P. Gertman,et al. The Appropriateness Evaluation Protocol: A Technique for Assessing Unnecessary Days of Hospital Care , 1981, Medical care.
[27] J. Mcgowan. Cost and benefit in control of nosocomial infection: methods for analysis. , 1981, Reviews of Infectious Diseases.
[28] R. Haley,et al. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. , 1981, The American journal of medicine.
[29] R. Haley,et al. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. , 1980, The Journal of infectious diseases.
[30] B. Rosner,et al. Adverse effects of nosocomial infection. , 1979, The Journal of infectious diseases.
[31] R. Wenzel,et al. Postoperative Wound Infection: A Controlled Study of the Increased Duration of Hospital Stay and Direct Cost of Hospitalization , 1977, Annals of surgery.
[32] E. Mortimer,et al. Importance of the carrier state as a source of Staphylococcus aureus in wound sepsis , 1969, Journal of Hygiene.
[33] J. Griffiths,et al. Nasal Staphylococci and Sepsis in Hospital Patients , 1959, British medical journal.
[34] H. J. Weinstein. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. , 1959, The New England journal of medicine.
[35] S. Clarke. Sepsis in surgical wounds with particular reference to staphylococcus aureus , 1957, British Journal of Surgery.